Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary (2009)
Chapter: 3 The Food and Drug Administration's Orphan Drug Program
Unfortunately, this book can't be printed from the OpenBook.
If you need to print pages from this book, we recommend
downloading it as a PDF.
Visit NAP.edu/10766 to get more information about this book, to buy it in print, or to download it as a free PDF.
Visit NAP.edu/10766 to get more information about this book, to buy it in print, or to download it as a free PDF.
Previous Chapter:
2 Current Model for Financing Drug Development: From Concept Through Approval
Next Chapter: 4 Diverse Funding Models
Suggested Citation:
"3 The Food and Drug Administration's Orphan Drug Program." Institute of Medicine. 2009. Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary. Washington, DC: The National Academies Press.
doi: 10.17226/12219.
Suggested Citation:
"3 The Food and Drug Administration's Orphan Drug Program." Institute of Medicine. 2009. Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary. Washington, DC: The National Academies Press.
doi: 10.17226/12219.
Suggested Citation:
"3 The Food and Drug Administration's Orphan Drug Program." Institute of Medicine. 2009. Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary. Washington, DC: The National Academies Press.
doi: 10.17226/12219.
Suggested Citation:
"3 The Food and Drug Administration's Orphan Drug Program." Institute of Medicine. 2009. Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary. Washington, DC: The National Academies Press.
doi: 10.17226/12219.
Suggested Citation:
"3 The Food and Drug Administration's Orphan Drug Program." Institute of Medicine. 2009. Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary. Washington, DC: The National Academies Press.
doi: 10.17226/12219.
Suggested Citation:
"3 The Food and Drug Administration's Orphan Drug Program." Institute of Medicine. 2009. Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary. Washington, DC: The National Academies Press.
doi: 10.17226/12219.
Suggested Citation:
"3 The Food and Drug Administration's Orphan Drug Program." Institute of Medicine. 2009. Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary. Washington, DC: The National Academies Press.
doi: 10.17226/12219.
Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.